» Articles » PMID: 35904250

CXCR4 Megakaryocytes Regulate Host-defense Immunity Against Bacterial Pathogens

Overview
Journal Elife
Specialty Biology
Date 2022 Jul 29
PMID 35904250
Authors
Affiliations
Soon will be listed here.
Abstract

Megakaryocytes (MKs) continuously produce platelets to support hemostasis and form a niche for hematopoietic stem cell maintenance in the bone marrow. MKs are also involved in inflammatory responses; however, the mechanism remains poorly understood. Using single-cell sequencing, we identified a CXCR4 highly expressed MK subpopulation, which exhibited both MK-specific and immune characteristics. CXCR4 MKs interacted with myeloid cells to promote their migration and stimulate the bacterial phagocytosis of macrophages and neutrophils by producing TNFα and IL-6. CXCR4 MKs were also capable of phagocytosis, processing, and presenting antigens to activate T cells. Furthermore, CXCR4 MKs also egressed circulation and infiltrated into the spleen, liver, and lung upon bacterial infection. Ablation of MKs suppressed the innate immune response and T cell activation to impair the anti-bacterial effects in mice under the challenge. Using hematopoietic stem/progenitor cell lineage-tracing mouse lines, we show that CXCR4 MKs were generated from infection-induced emergency megakaryopoiesis in response to bacterial infection. Overall, we identify the CXCR4 MKs, which regulate host-defense immune response against bacterial infection.

Citing Articles

Megakaryocyte in sepsis: the trinity of coagulation, inflammation and immunity.

Hua T, Yao F, Wang H, Liu W, Zhu X, Yao Y Crit Care. 2024; 28(1):442.

PMID: 39741325 PMC: 11689543. DOI: 10.1186/s13054-024-05221-6.


Versatility of megakaryocytes in homeostasis and disease.

Wang D, Xie J, Zhao M Blood Sci. 2024; 6(4):e00212.

PMID: 39620204 PMC: 11608743. DOI: 10.1097/BS9.0000000000000212.


Pim Kinase Inhibition Disrupts CXCR4 Signalling in Megakaryocytes and Platelets by Reducing Receptor Availability at the Surface.

Nock S, Blanco-Lopez M, Stephenson-Deakin C, Jones S, Unsworth A Int J Mol Sci. 2024; 25(14).

PMID: 39062849 PMC: 11276893. DOI: 10.3390/ijms25147606.


Understanding megakaryocyte phenotypes and the impact on platelet biogenesis.

Chen S, Looney M Transfusion. 2024; 64(7):1372-1380.

PMID: 38923572 PMC: 11251837. DOI: 10.1111/trf.17927.


Research progress of megakaryocytes and platelets in lung injury.

Hua T, Zhang G, Yao Y, Jia H, Liu W Ann Med. 2024; 56(1):2362871.

PMID: 38902986 PMC: 11195464. DOI: 10.1080/07853890.2024.2362871.


References
1.
Haas S, Hansson J, Klimmeck D, Loeffler D, Velten L, Uckelmann H . Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors. Cell Stem Cell. 2015; 17(4):422-34. DOI: 10.1016/j.stem.2015.07.007. View

2.
Yang M, Li K, Chui C, Yuen P, Chan P, Chuen C . Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. Br J Haematol. 2000; 111(1):371-80. DOI: 10.1046/j.1365-2141.2000.02340.x. View

3.
Deutsch V, Tomer A . Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. Br J Haematol. 2013; 161(6):778-93. DOI: 10.1111/bjh.12328. View

4.
Sacma M, Pospiech J, Bogeska R, de Back W, Mallm J, Sakk V . Haematopoietic stem cells in perisinusoidal niches are protected from ageing. Nat Cell Biol. 2019; 21(11):1309-1320. DOI: 10.1038/s41556-019-0418-y. View

5.
Cunin P, Nigrovic P . Megakaryocytes as immune cells. J Leukoc Biol. 2019; 105(6):1111-1121. PMC: 6984013. DOI: 10.1002/JLB.MR0718-261RR. View